Position in CDXS
as of Mar 31, 2026
· filed Jun 1, 2026
Position Value
$17,245
New position
Shares Held
10,580
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caerus Investment Advisors, LLC holds $2,701,203 across 9 Biotechnology names. CDXS ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,666 | $1,287,218 | |
| 2 | INCY |
Incyte Corp
|
5,694 | $535,919 | |
| 3 | EXEL |
Exelixis, Inc.
|
7,661 | $328,580 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
4,905 | $277,083 | |
| 5 | SRPT |
Sarepta Therapeutics, Inc.
|
9,854 | $214,423 | |
| 6 | ALDX |
Aldeyra Therapeutics, Inc.
|
11,455 | $19,358 | |
| 7 | FATE |
Fate Therapeutics Inc
|
14,569 | $17,482 | |
| 8 | CDXS |
Codexis, Inc.
This page
|
10,580 | $17,245 |
All Filings in CDXS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,245 | 10,580 | Shares | Sole | 2026-06-01 | |
| No filing history on record for this holder in this stock. | ||||||